Tomofumi Ishikawa
16PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (16)
Sort by Publication Date:
|Feb 27, 2026
Long-term safety and effectiveness of rimegepant for the preventive treatment of migraine in Japan: an open-label extension of a phase 3 study.Yasuhiko Matsumori, Shigekazu Kitamura, Toshimasa Yamamoto
|Nov 17, 2025
Plain Language Summary Publication: Efficacy and safety of rimegepant for the preventive treatment of migraine in Japan: A double-blind, randomized controlled trial.Shigekazu Kitamura, Yasuhiko Matsumori, Toshimasa Yamamoto
|Jun 30, 2025
Efficacy and safety of rimegepant for the acute treatment of migraine in Japan: A dose-ranging, double-blind, randomized controlled trial.Koichi Ikeda, Yasuhiko Matsumori, Masako Kudo
|Jun 21, 2025
Efficacy and safety of rimegepant for the preventive treatment of migraine in Japan: A double-blind, randomized controlled trial.Shigekazu Kitamura, Yasuhiko Matsumori, Toshimasa Yamamoto
|Sep 05, 2024
Association between exposure to atypical antipsychotics during pregnancy and risk of miscarriage.Tomofumi Ishikawa, Takamasa Sakai, Noriyuki Iwama
|Sep 09, 2023
Real-world prevalence, time of diagnosis, and co-occurrence patterns of birth defects in live-born infants, 2014-2020: A health administrative database study in Japan.Tomofumi Ishikawa, Hiroshi Kawame, Nariyasu Mano
Pageof 3
